- Home
- App Analytics
- SurvivorNet
- SurvivorNet Vs. Multiple Myeloma Management
SurvivorNet vs Multiple Myeloma Management Usage & Stats
We believe far too many people still struggle to find information about treatments that can save their lives. SurvivorNet is closing this gap by creating a deep, video-based educational resource for patients featuring top physicians and researchers around the country. To create patient-focused educational content, the company is working with physicians at leading NCCN-designated cancer centers such as The National Cancer Institute, Dana-Farber, Memorial Sloan Kettering, Stanford, NYU, and M.D. Anderson.
- Apple App Store
- Free
- Health & Fitness
Store Rank
- -
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- Apple App Store
- Free
- Medical
Store Rank
- -
SurvivorNet vs. Multiple Myeloma Management ranking comparison
Compare SurvivorNet ranking trend in the past 28 days vs. Multiple Myeloma Management
Rank
No Data Available
SurvivorNet vs. Multiple Myeloma Management ranking by country comparison
Compare SurvivorNet ranking trend in the past 28 days vs. Multiple Myeloma Management
No Data to Display
Compare to any site with our free trial
SurvivorNet VS.
Multiple Myeloma Management
December 17, 2024